Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

External use medicine composition for treating chilblain, external use unguent for treating chilblain and preparation method of external use unguent

A technology for external use medicine and composition, which is applied in the field of external use medicine composition for treating chilblain and external ointment for treating chilblain, can solve the problems of high cost, long healing period, inability to relieve symptoms of patients and the like

Inactive Publication Date: 2015-11-04
万小耀
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Going for medical treatment is time-consuming and expensive. For mild frostbite, most people often do not go to clinics or hospitals for treatment, and treat or let them heal on their own
In the face of different chilblain symptoms, non-standard treatments often take a long time to cure, fail to relieve the symptoms of patients, and even lead to other more serious problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Prepare the external pharmaceutical composition for treating chilblain according to the following raw materials in parts by weight: 80 parts by weight of safflower, 90 parts by weight of Daphne genkwa; 20 parts by weight of comfrey, 20 parts by weight of cinnabar root, 25 parts by weight of Tribulus terrestris, and 25 parts by weight of catechu 10 parts by weight of borneol, 12 parts by weight of cinnamon, 10 parts by weight of Panax notoginseng, 15 parts by weight of Xu Changqing, 5 parts by weight of sodium chloride, 7 parts by weight of Angelica dahurica, 7 parts by weight of Sophora flavescens, 10 parts by weight of Fructus Cnidii; Achyranthes bidentata 25 parts by weight Parts by weight, angelica 25 parts by weight.

Embodiment 2

[0065] The external pharmaceutical composition for treating frostbite is made of the following raw materials by weight: 90 parts by weight of safflower, 100 parts by weight of Daphne genkwa; 25 parts by weight of comfrey, 25 parts by weight of cinnabar root, 30 parts by weight of tribulus terrestris, and catechu 30 parts by weight; 12 parts by weight of borneol, 15 parts by weight of cinnamon, 12 parts by weight of Panax notoginseng, 10 parts by weight of Xu Changqing, 7 parts by weight of sodium chloride, 10 parts by weight of Angelica dahurica, 10 parts by weight of Sophora flavescens, 5 parts by weight of Fructus Cnidii; Knee 20 parts by weight, Angelica 30 parts by weight.

Embodiment 3

[0067] Prepare the external pharmaceutical composition for treating chilblain according to the following raw materials in parts by weight: 100 parts by weight of safflower, 80 parts by weight of Daphne genkwa; 30 parts by weight of comfrey, 30 parts by weight of cinnabar root, 25 parts by weight of Tribulus terrestris, and 25 parts by weight of catechu 15 parts by weight of borneol, 10 parts by weight of cinnamon, 15 parts by weight of Panax notoginseng, 12 parts by weight of Xu Changqing, 10 parts by weight of sodium chloride, 5 parts by weight of Angelica dahurica, 5 parts by weight of Sophora flavescens, 7 parts by weight of Fructus Cnidii; Achyranthes bidentata 30 Parts by weight, angelica 20 parts by weight.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an external use medicine composition for treating chilblain. The composition is composed of flos carthami, daphne genkwa, shikonin, coral ardisia root, tribulus terrestris, cutch, borneol, cinnamon, panax notoginseng, radix cynanchi panicullati, sodium chloride, radix angelicae dahuricae, sophora flavescens, fructus cnidii, achyranthes bidentata and angelica sinensis. The invention further provides external use unguent for treating chilblain and a preparation method of the external use unguent. The external use medicine composition and the external use unguent have the advantages of having the functions of invigorating blood circulation and dredging meridian, relieving swelling and pain, and relieving itching and eliminating discomfort.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations, and in particular relates to an external pharmaceutical composition for treating chilblain, an external ointment for treating chilblain and a preparation method thereof. Background technique [0002] Chilblain is a localized erythematous inflammatory disease that occurs in the peripheral parts after the body is attacked by cold. It is a localized inflammatory erythematous lesion caused by combined exposure to low temperature above freezing point and high humidity (humid environment). It is easy to occur in a humid and cold environment with a temperature below 10°C. The parts are mostly in the auricles, hands, feet, etc., with local redness, purpleness, swelling, itching, and sometimes blisters, erosion, ulceration, and insanity. [0003] Frostbite is especially common in the mountainous areas of the south in winter. There is no heating in the south in wint...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/83A61K9/70A61P17/02A61K33/26A61K33/14A61K33/44A61K31/045
Inventor 万小耀
Owner 万小耀
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products